Description

EVERMIL 10 MG

Indications

EVERMIL 10 MG is primarily indicated for the treatment of various forms of hypertension (high blood pressure) and for the management of heart failure. It is also utilized in certain cases of angina pectoris (chest pain due to reduced blood flow to the heart). The active ingredient in EVERMIL, which is a calcium channel blocker, helps to relax the blood vessels, thereby lowering blood pressure and reducing the workload on the heart.

Mechanism of Action

EVERMIL 10 MG contains amlodipine as its active ingredient, which belongs to the class of medications known as dihydropyridine calcium channel blockers. The primary mechanism of action involves the inhibition of calcium ions from entering the vascular smooth muscle and cardiac muscle. By blocking these calcium channels, amlodipine causes vasodilation (widening of blood vessels), which leads to a decrease in peripheral vascular resistance and subsequently lowers blood pressure. Additionally, by reducing the amount of calcium available for muscle contraction in the heart, it decreases myocardial oxygen demand, making it beneficial in the management of angina.

Pharmacological Properties

EVERMIL is characterized by its long half-life, allowing for once-daily dosing. It is well-absorbed from the gastrointestinal tract, with peak plasma concentrations typically occurring within 6 to 12 hours after administration. The drug is extensively metabolized in the liver, primarily via the cytochrome P450 system, and excreted mainly through the urine. Its pharmacokinetic profile supports its effectiveness in managing chronic conditions such as hypertension and angina, providing sustained blood pressure control over a 24-hour period.

Contraindications

EVERMIL 10 MG is contraindicated in patients with known hypersensitivity to amlodipine or any of the excipients in the formulation. It should not be used in individuals with severe aortic stenosis, cardiogenic shock, or unstable angina. Additionally, caution is advised when prescribing EVERMIL to patients with hepatic impairment, as the metabolism of the drug may be significantly altered in such cases.

Side Effects

Like all medications, EVERMIL 10 MG may cause side effects. Commonly reported adverse effects include peripheral edema (swelling of the extremities), dizziness, fatigue, palpitations, and flushing. Less frequently, patients may experience gastrointestinal disturbances, such as nausea or abdominal pain. Serious side effects, although rare, can include hypotension, angina exacerbation, or allergic reactions. Patients should be advised to report any unusual symptoms to their healthcare provider promptly.

Dosage and Administration

The recommended starting dose of EVERMIL 10 MG for adults is one tablet taken orally once daily. Depending on the patient’s response and clinical condition, the dose may be adjusted. It is important to take EVERMIL at the same time each day to maintain consistent blood levels. The medication can be taken with or without food. Patients should be instructed not to exceed the prescribed dose and to consult their healthcare provider if they miss a dose.

Interactions

EVERMIL 10 MG may interact with several other medications, which can affect its efficacy and safety. Concomitant use with other antihypertensive agents may lead to additive hypotensive effects. Additionally, caution is warranted when used with strong CYP3A4 inhibitors (such as ketoconazole or erythromycin), as they may increase amlodipine levels in the blood. Conversely, medications that induce CYP3A4 (such as rifampin) may decrease the effectiveness of EVERMIL. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and herbal supplements.

Precautions

Before initiating treatment with EVERMIL 10 MG, a thorough medical history and physical examination should be conducted. Patients with a history of heart failure, liver disease, or renal impairment should be monitored closely during therapy. It is also essential to assess the patient’s blood pressure regularly to ensure adequate control. Special caution is advised in elderly patients, as they may be more sensitive to the effects of the medication. Pregnant or breastfeeding women should consult their healthcare provider before using EVERMIL, as its safety in these populations has not been fully established.

Clinical Studies

Clinical studies have demonstrated the efficacy of EVERMIL 10 MG in lowering blood pressure and improving exercise tolerance in patients with angina. In a randomized, double-blind trial, patients treated with amlodipine experienced a significant reduction in systolic and diastolic blood pressure compared to placebo. Furthermore, studies have shown that amlodipine is effective in reducing the frequency of angina attacks and improving quality of life in patients with stable angina pectoris. Long-term studies indicate that EVERMIL is well-tolerated, with a favorable safety profile over extended periods of use.

Conclusion

EVERMIL 10 MG is a valuable therapeutic option for the management of hypertension and angina. Its unique mechanism of action, favorable pharmacokinetic properties, and extensive clinical evidence support its use in a wide range of patients. However, as with any medication, it is crucial to use EVERMIL responsibly, adhering to prescribed dosages and monitoring for potential side effects. Patients should maintain open communication with their healthcare providers to ensure optimal management of their condition.